Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

  • There is currently no data for JWNG

Trading Statement

30 Mar 2012 13:08

RNS Number : 4894A
WEARE 2020 PLC
30 March 2012
 



 

 

 

 

Weare2020 plc

(the "Company" or "Group")

 

Trading Update

 

 30 March 2012

 

 

Weare2020plc, the digital marketing group, provides a trading update ahead of the publication of its preliminary results to 31 March 2012.

 

Our interim results to September 2011 showed significant progress for the Group. Despite a decline in gross profit as a result of the consolidation of the operations in Nottingham and the impact of the economic environment on 2020 Agency, the Company posted PBT of £1.01m on a gross profit of £15.25m.

 

A number of clients have deferred their expenditure decisions which has affected 2020 Technology, our e-commerce project implementation division, in particular. The Group expects to report revenues of £38m. On the positive side 2020 Dialogue, our lead generation and data and risk business continued to perform well and above expectations. The Group's adjusted PBT has also been affected by a requirement to make a one-off provision in relation to certain fees in dispute amounting to £200,000. As a result the Group expects to report an adjusted PBT of £3.1m.

 

The Group expects to publish its preliminary results in the week beginning 25 June 2012.

 

Enquiries:

Weare2020 plc

Keith Sadler 079122 74522

COO, Group Finance Director

 

Cenkos Securities plc

Ivonne Cantu (Nomad) 020 7397 8980

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTURRURUNAOOAR
Date   Source Headline
13th Feb 20257:00 amRNSCancellation - Jaywing Plc
5th Feb 202510:39 amRNSResult of GM, Cancellation of Admission to Trading
21st Jan 20254:18 pmRNSCircular Amendment
14th Jan 20257:00 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSPublication of Circular and Notice of GM
23rd Dec 20243:02 pmRNSNotice of Requisition of General Meeting
19th Dec 20247:00 amRNSInterim Results
3rd Dec 20247:00 amRNSChange of Registered Office
7th Oct 20247:00 amRNSIncrease in Loan Facility
1st Oct 20247:00 amRNSTrading update and further funding
26th Sep 20242:42 pmRNSResult of AGM
4th Sep 20244:59 pmRNSHolding(s) in Company
3rd Sep 20247:00 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSFinal Results
31st Jul 20241:58 pmRNSStatement regarding share price movement
21st Jun 202412:01 pmRNSUpdate on Loan Facility
28th May 20245:38 pmRNSIncrease in Loan Facility
13th May 20247:00 amRNSBoard, Trading Update, Strategic Review Conclusion
3rd Apr 202411:04 amRNSBoard Appointments
26th Mar 20241:57 pmRNSForm 8.3 - Jaywing PLC
18th Mar 20245:39 pmRNSForm 8.3 - Jaywing Plc
18th Mar 20245:31 pmRNSForm 8.3 - Jaywing plc
18th Mar 20242:02 pmRNSForm 8.3 - Jaywing plc
15th Mar 20244:45 pmRNSForm 8.3 - Jaywing Plc
15th Mar 20244:21 pmRNSForm 8.3 - Jaywing plc
14th Mar 20245:43 pmRNSForm 8.3 - Jaywing plc
14th Mar 20244:14 pmRNSForm 8.3 - Jaywing Plc
14th Mar 20241:53 pmRNSForm 8.3 - Jaywing PLC
7th Mar 20243:00 pmRNSForm 8
6th Mar 202411:09 amRNSForm 8.3 - Jaywing PLC
4th Mar 20243:56 pmRNSForm 8.3 - Jaywing plc
4th Mar 20249:25 amRNS2.9 Announcement
4th Mar 20247:00 amRNSTrading update, Loan Facility and Strategic Review
21st Dec 20237:00 amRNSHalf-year Report
20th Oct 20237:00 amRNSAppointment of Nominated Adviser and Broker
28th Sep 20234:28 pmRNSResult of AGM
7th Sep 20237:00 amRNSFinal Results
13th Apr 20237:00 amRNSGrant of Share Options
16th Feb 20237:00 amRNSTrading Update
14th Feb 202311:37 amRNSAIM Rule 17 Notification
5th Jan 20233:57 pmRNSHolding(s) in Company
1st Dec 20226:11 pmRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSHalf-year Report
11th Nov 202212:42 pmRNSHolding(s) in Company
8th Nov 20222:29 pmRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
29th Sep 20223:49 pmRNSResult of AGM
6th Sep 20222:01 pmRNSFinal Results
26th Aug 202211:59 amRNSAcquisition of Midisi Limited (replacement)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.